Twofold illumination photodynamic therapy scheme for subfoveal choroidal neovascularization in pathologic myopia: Results from a randomized pilot study

Retina

Volumn 26, Issue 7, 2006, Pages 757-764

  Costa, Rogirio A ^a,b   Williams, George A ^c  

^a Hospital de Olhos de Araraquara   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Choroidal neovascularization; Fluorescein angiography; Laser; Myopia; Photodynamic therapy

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; FLUORESCEIN;

ADULT; AGED; ARTICLE; CAMERA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FISHER EXACT TEST; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; ILLUMINATION; INTERMETHOD COMPARISON; MALE; MYOPIA; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; RETREATMENT; STANDARD; SUBRETINAL NEOVASCULARIZATION; VISION; VISUAL ACUITY; WILCOXON SIGNED RANKS TEST;

ADULT; AGED; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FOVEA CENTRALIS; HUMANS; MALE; MIDDLE AGED; MYOPIA, DEGENERATIVE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PILOT PROJECTS; PORPHYRINS; RETREATMENT; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 33748661721     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iae.0000244260.52901.2e     Document Type: Article

References (21)

1. Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial-VIP report no. 1. Ophthalmology 2001;108:841-852.
2. Blinder KJ, Blumenkranz MS, Bressler NM, et al. Vertepor-fin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial-VIP report no. 3. Ophthalmology 2003;110:667-673.
3. Thomas MA, Dickinson JD, Melberg NS, et al. Visual results after surgical removal of subfoveal choroidal neovascular membranes. Ophthalmology 1994;101:1384-1396.
4. Bottoni F, Airaghi P, Perego E, et al. Surgical removal of idiopathic, myopic, and age-related subfoveal neovascularization. Graefes Arch Clin Exp Ophthalmol 1996;234:S42-S50.
5. Fujikado T, Ohji M, Hayashi A, Kusaka S, Tano Y. Anatomic and functional recovery of the fovea after foveal translocation surgery without large retinotomy and simultaneous excision of a neovascular membrane. Am J Ophthalmol 1998;126:839-842.
6. Fujii GY, Humayun MS, Pieramici DJ, et al. Initial experience of inferior limited macular translocation for subfoveal choroidal neovascularization resulting from causes other than age-related macular degeneration. Am J Ophthalmol 2001;131:90-100.
7. Hamelin N, Glacet-Bernard A, Brindeau C, et al. Surgical treatment of subfoveal neovascularization in myopia: macular translocation vs surgical removal. Am J Ophthalmol 2002;133:530-536.
8. Costa RA, Calucci D, Teixeira LF, et al. Selective occlusion of subfoveal choroidal neovascularization in pathologic myopia using a new technique of ingrowth site treatment. Am J Ophthalmol 2003;135:857-866.
9. Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ. Etiology of choroidal neovascularization in young patients. Ophthalmology 1996;103:1241-1244.
10. Avila MP, Weiter JJ, Jalkh AE, et al. Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 1984;91:1573-1581.
11. Yoshida T, Ohno-Matsui K, Ohtake Y, et al. Long-term visual prognosis of choroidal neovascularization in high myopia. Ophthalmology 2002;109:712-719.
12. Stur M, Ansari-Shahrezaei S. The effect of axial length on laser spot size and laser irradiance. Arch Ophthalmol 2001;119:1323-1328.
13. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials-TAP report no. 1. Arch Ophthalmol 1999;117:1329-1345.
14. Yoshida T, Ohno-Matsui K, Ohtake Y, et al. Long-term visual prognosis of choroidal neovascularization in high myopia: a comparison between age groups. Ophthalmology 2002;109:712-719.
15. Bressler NM. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-TAP report no. 2. Arch Ophthalmol 2001;119:198-207.
16. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol 1992;55:145-157.
17. Grossweiner LI. The Science of Phototherapy. Boca Raton, FL: CRC Press, 1994;27-49, 139-155, 175-177.
18. Dougherty TJ, Grindey GB, Fiel R, Weishaupt KR, Boyle DG. Photoradiation therapy II: cure of animal tumors with hematoporphyrin and light. J Natl Cancer Inst 1975;55:115-121.
19. Manyac MJ, Russo A, Smith PD, Glatstein E. Photodynamic therapy. J Clin Oncol 1988;6:380-391.
20. Mainster MA, Crossman JL, Erickson PJ, Heacock GL. Retinal laser lenses: magnification, spot size, and field of view. Br J Ophthalmol 1990;74:177-179.
21. Miller JW, Schmidt-Erfurth U, Sickenberg M, et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol 1999;117:1161-1173.